Le Lézard
Classified in: Health
Subjects: NPT, CHI, LGB, AVO, DEI

Do No Harm Unveils Groundbreaking Detransitioner Bill of Rights


Model legislation extends ethical care and rights to children harmed by experimental sex change procedures

RICHMOND, Va., Oct. 17, 2023 /PRNewswire/ -- Do No Harm, a prominent national nonprofit committed to safeguarding healthcare from radical and divisive ideology, published the first-of-its-kind Detransitioner Bill of Rights. This pioneering model legislation is designed to provide support and justice to those who have been abandoned by the medical community when seeking to detransition from harmful and experimental sex change treatments they received as children.

"The Detransitioner Bill of Rights represents a crucial step in protecting the rights and well-being of children who have been subjected to experimental sex change treatments," said Dr. Stanley Goldfarb, Do No Harm Chairman. "Medical professionals should publicly acknowledge the plight of detransitioners and research ways to help and support those who regret undergoing these procedures."

CLICK HERE to read the full text of the Detransitioner Bill of Rights.

The Detransitioner Bill of Rights is a comprehensive piece of legislation that advocates for six fundamental rights for detransitioners, addressing critical issues that currently lack adequate legal protection:

"We cannot remain passive while the well-being and rights of children are at risk," said Do No Harm Executive Director Kristina Rasmussen. "The Detransitioner Bill of Rights is a significant step toward helping young people who've been funneled toward treatments that can lead to life-long suffering."

Do No Harm is making the nonpartisan model legislation available to all, including state and federal policymakers, thereby reinforcing the protection of patient rights and upholding ethical healthcare practices. The organization encourages everyone to join their mission in supporting the Detransitioner Bill of Rights, striving for its broadest and most enduring impact.

For more information about the Detransitioner Bill of Rights or to support Do No Harm's mission, please visit their website at [https://donoharmmedicine.org/bill-of-rights/].

Do No Harm, established in April 2022, has rapidly gained recognition and made significant strides in its mission to safeguard healthcare from ideological threats. With more than 5,000 members, including doctors, nurses, physicians, and concerned citizens across all 50 states and in 14 countries, DNH has achieved more than 4,900 media hits in top-tier publications and garnered widespread attention through numerous broadcast news appearances.

SOURCE Do No Harm


These press releases may also interest you

at 07:13
Webblogic®, a pioneer in medical device manufacturing technology, is set to launch its comprehensive range of advanced manufacturing and packaging equipment specifically designed for the Medical Device, Pharma, and Life Sciences industries. In...

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

18 mai 2024
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...



News published on and distributed by: